These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 19651509)
1. Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors. González A; Quirante J; Nieto J; Almeida MR; Saraiva MJ; Planas A; Arsequell G; Valencia G Bioorg Med Chem Lett; 2009 Sep; 19(17):5270-3. PubMed ID: 19651509 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. Green NS; Palaninathan SK; Sacchettini JC; Kelly JW J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036 [TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design. Cardoso I; Almeida MR; Ferreira N; Arsequell G; Valencia G; Saraiva MJ Biochem J; 2007 Nov; 408(1):131-8. PubMed ID: 17683281 [TBL] [Abstract][Full Text] [Related]
4. Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state. Petrassi HM; Johnson SM; Purkey HE; Chiang KP; Walkup T; Jiang X; Powers ET; Kelly JW J Am Chem Soc; 2005 May; 127(18):6662-71. PubMed ID: 15869287 [TBL] [Abstract][Full Text] [Related]
5. Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation. Johnson SM; Petrassi HM; Palaninathan SK; Mohamedmohaideen NN; Purkey HE; Nichols C; Chiang KP; Walkup T; Sacchettini JC; Sharpless KB; Kelly JW J Med Chem; 2005 Mar; 48(5):1576-87. PubMed ID: 15743199 [TBL] [Abstract][Full Text] [Related]
6. Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors. Dolado I; Nieto J; Saraiva MJ; Arsequell G; Valencia G; Planas A J Comb Chem; 2005; 7(2):246-52. PubMed ID: 15762752 [TBL] [Abstract][Full Text] [Related]
7. Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. Sriram D; Bal TR; Yogeeswari P J Pharm Pharm Sci; 2005 Oct; 8(3):565-77. PubMed ID: 16401403 [TBL] [Abstract][Full Text] [Related]
8. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. Adamski-Werner SL; Palaninathan SK; Sacchettini JC; Kelly JW J Med Chem; 2004 Jan; 47(2):355-74. PubMed ID: 14711308 [TBL] [Abstract][Full Text] [Related]
9. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition. Julius RL; Hawthorne MF Drug News Perspect; 2008 Jun; 21(5):258-66. PubMed ID: 18596990 [TBL] [Abstract][Full Text] [Related]
10. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors. Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. Diaz P; Xu J; Astruc-Diaz F; Pan HM; Brown DL; Naguib M J Med Chem; 2008 Aug; 51(16):4932-47. PubMed ID: 18666769 [TBL] [Abstract][Full Text] [Related]
12. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis. Wiseman RL; Green NS; Kelly JW Biochemistry; 2005 Jun; 44(25):9265-74. PubMed ID: 15966751 [TBL] [Abstract][Full Text] [Related]
13. Chemical synthesis, in vitro acetohydroxyacid synthase (AHAS) inhibition, herbicidal activity, and computational studies of isatin derivatives. Wang J; Tan H; Li Y; Ma Y; Li Z; Guddat LW J Agric Food Chem; 2011 Sep; 59(18):9892-900. PubMed ID: 21838297 [TBL] [Abstract][Full Text] [Related]
14. 6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction. Diaz P; Phatak SS; Xu J; Astruc-Diaz F; Cavasotto CN; Naguib M J Med Chem; 2009 Jan; 52(2):433-44. PubMed ID: 19115816 [TBL] [Abstract][Full Text] [Related]
15. Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates. Gupta S; Chhibber M; Sinha S; Surolia A J Med Chem; 2007 Nov; 50(23):5589-99. PubMed ID: 17948976 [TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors. Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564 [TBL] [Abstract][Full Text] [Related]
17. QSAR study of isatin analogues as in vitro anti-cancer agents. Sabet R; Mohammadpour M; Sadeghi A; Fassihi A Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518 [TBL] [Abstract][Full Text] [Related]